Cargando…

Peripheric arterial aneurisyms and monocytosis in intravenous immunoglobulin treatment resistant Kawasaki disease

Detalles Bibliográficos
Autores principales:	Baskin, E, Bayrakci, US, Di, Konuksever, Turkay, S, Varan, B, Ercoban, H, Avci, Z
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334083/ http://dx.doi.org/10.1186/1546-0096-6-S1-P274

Ejemplares similares

PReS-FINAL-2087: Diagnosis of arthritis: history or laboratory?
por: Yurtsever, O, et al.
Publicado: (2013)

PReS-FINAL-2262: Arthritis in a patient with type 1 glycogen storage disease
por: Baskin, E, et al.
Publicado: (2013)

The association of Familial Mediterranean Fever and cryptogenic cirrhosis
por: Baskin, E, et al.
Publicado: (2008)

Rituximab for treatment of severe lupus nephritis
por: Baskin, E, et al.
Publicado: (2008)

High incidence of adrenal suppression in children with Kawasaki disease treated with intravenous immunoglobulin plus prednisolone
por: Goto, Masahiro, et al.
Publicado: (2015)

PReS-FINAL-2214: Validation of new pediatric criteria in diagnosis of Familial Mediterranean Fever in children
por: Baskin, E, et al.
Publicado: (2013)

1025. Prediction of Intravenous Immunoglobulin Resistance and Coronary Artery Dilatation in Kawasaki Disease: a Multicenter Study from Oman
por: Al Mwaiti, Fatma, et al.
Publicado: (2021)

Intravenous immunoglobulin for the treatment of Kawasaki disease
por: Broderick, Cathryn, et al.
Publicado: (2023)

Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease
por: Xie, Tian, et al.
Publicado: (2017)

The Diagnostic Value of a Monocytosis
por: Dutton, H. R.
Publicado: (1928)

The role of monocytosis and neutrophilia in atherosclerosis
por: Chistiakov, Dimitry A., et al.
Publicado: (2018)

Use of Intravenous Immunoglobulin Therapy in a paediatric rheumatology service
por: Saladi, SM, et al.
Publicado: (2008)

Intravenous immunoglobulin therapy could have efficacy in severe sepsis
por: Kim, Ahmin, et al.
Publicado: (2013)

Use of intravenous immunoglobulin to treat sepsis in a general ICU
por: Drakeford, Y, et al.
Publicado: (2015)

Predictive factors of resistance to intravenous immunoglobulin and coronary artery lesions in Kawasaki disease
por: Lee, Hye Young, et al.
Publicado: (2016)

ZNFX1 Deficiency in a Child with Interstitial Pneumonitis and Peripheral Monocytosis
por: Al-Saud, Bandar, et al.
Publicado: (2023)

Coronary artery abnormalities in Kawasaki disease according to patient age
por: Nuñez, Esmeralda, et al.
Publicado: (2011)

Intravenous immunoglobulins prevent breakdown of the blood-brain barrier in experimental sepsis
por: Esen, F, et al.
Publicado: (2010)

Levels of soluble fibrin in severe septic patients given intravenous immunoglobulin
por: Kobayashi, T, et al.
Publicado: (2009)

Intravenous immunoglobulins versus plasma exchange in the treatment of Guillain-Barré syndrome
por: Charra, B, et al.
Publicado: (2009)

Comparative study between intravenous immunoglobulins and standard treatment in septic patients
por: Hamed, G, et al.
Publicado: (2008)

Usefulness of intravenous immunoglobulin administration to sepsis-induced coagulopathy in ICU patients
por: Matsumoto, N, et al.
Publicado: (2014)

Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease
por: Park, Hyo Min, et al.
Publicado: (2013)

Predictors and management of intravenous immunoglobulin-resistant Kawasaki disease
por: Song, Min Seob
Publicado: (2019)

Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin
por: Galeotti, Caroline, et al.
Publicado: (2010)

Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease
por: Li, Wei, et al.
Publicado: (2022)

Intravenous Immunoglobulin in Kawasaki Disease—Evolution and Pathogenic Mechanisms
por: Nadig, Pallavi L., et al.
Publicado: (2023)

Use of intravenous and intramuscular immunoglobulin in the practice of treatment for purulent and septic deaths in newborns
por: Khanes, G, et al.
Publicado: (2012)

Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Ma, Yongmei, et al.
Publicado: (2022)

The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?
por: Han, Ji Whan
Publicado: (2017)

Effect of intravenous immunoglobulin in critically ill adult patients with sepsis: a meta-analysis
por: Turgeon, A, et al.
Publicado: (2006)

Effect of intravenous administration of freeze-dried sulfonated human normal immunoglobulin for septic patients
por: Deguchi, Y, et al.
Publicado: (2009)

Prediction of Resistance to Standard Intravenous Immunoglobulin Therapy in Kawasaki Disease
por: Lee, Sang Min, et al.
Publicado: (2014)

Hemolysis From Intravenous Immunoglobulin in Obese Patients With Kawasaki Disease
por: Van Anh, Khanh-Van Y., et al.
Publicado: (2020)

Intravenous Immunoglobulin Treatment in Kawasaki Disease Decreases the Incidence of Myopia
por: Yu, Hun-Ju, et al.
Publicado: (2021)

Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease
por: Lu, Yaheng, et al.
Publicado: (2021)

Retracted: Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Healthcare Engineering, Journal of
Publicado: (2023)

Recurrent refractory Kawasaki disease
por: Costa Reis, P, et al.
Publicado: (2011)

THE CYTOKINETICS OF MONOCYTOSIS IN ACUTE SALMONELLA INFECTION IN THE RAT
por: Volkman, Alvin, et al.
Publicado: (1974)

Monocytosis in the BXSB model for systemic lupus erythematosus
Publicado: (1984)

Cannot write session to /tmp/vufind_sessions/sess_fv3of3gfrgnq8gd0trgdcf1309